Report cover image

Transplant Diagnostics Market by Offering (Instruments, Reagents & Consumables, Software & Services), Technology (Molecular Assays, Non-Molecular Assays), Transplant, Application, End User - Global Forecast 2024-2030

Publisher 360iResearch
Published Jan 15, 2024
Length 191 Pages
SKU # IRE18450815

Description

Transplant Diagnostics Market by Offering (Instruments, Reagents & Consumables, Software & Services), Technology (Molecular Assays, Non-Molecular Assays), Transplant, Application, End User - Global Forecast 2024-2030


The Transplant Diagnostics Market size was estimated at USD 4.59 billion in 2023 and expected to reach USD 4.91 billion in 2024, at a CAGR 7.55% to reach USD 7.65 billion by 2030.

Global Transplant Diagnostics MarketTransplant diagnostics are tests to check the compatibility between the donor and recipient of an organ before or after transplant to reduce the risk of organ rejection and improve the success rate of transplants. Transplant diagnostics tests are used in various disciplines, such as immunogenetics, pathology, and infectious diseases. Transplant diagnostics also help improve transplant recipients' quality of life by providing more accurate and timely diagnosis and treatment. Increasing awareness of organ donation & transplant, increasing focus on research and development of transplant diagnostics, and rapid new technological development drive the market growth. However, the high cost of transplantation and treatment using advanced modalities and technology products may limit end users' adoption of transplant diagnostics. New technological advancements, regulatory guidelines for transplant diagnostics, and strategic initiatives by the market players are expected to create new opportunities for the market.

Regional Insights

The Americas is a significant market in transplant diagnostics due to growth in the geriatric population and the increase in infectious diseases. The new product development by key market players, financed organizations, infrastructure, and government participation in increasing funds and awareness to encourage the transplantation of organs for patients are the major factors for the market growth in the region. The rising investment in the medical sector from the private sector is also vital for the global transplant diagnostics market. The rise in transplant diagnostic surgeries, increasing demand from emerging markets, and expansion of healthcare industries are significant factors of the market adoption in the European market. Moreover, the Asia-Pacific transplant diagnostics market is expected to grow due to the rising number of organ donation camps and awareness programs across the region. Increasing adoption of technological development in transplant diagnostics is anticipated to boost the market growth.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Transplant Diagnostics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Transplant Diagnostics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Transplant Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Adaptive Biotechnologies Corporation, altona Diagnostics GmbH, Arquer Diagnostics Ltd., BAG Group, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biogenuix Medsystems Pvt. Ltd, BioMérieux SA, Bruker Corporation, CareDx, Inc., CLONIT srl, Diagnóstica Longwood SL, DiaSorin S.p.A., Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., Genome Diagnostics B.V., Hologic, Inc., Illumina, Inc, Immucor, Inc., Laboratory Corporation of America Holdings, Luminex Corporation, Merck KGaA, NanoString Technologies, Inc., Novartis AG, PathoNostics B.V, QIAGEN, N.V., Quest Diagnostics Incorporated, Randox Laboratories Ltd., Takara Bio Inc., Thermo Fisher Scientific Inc., TransMedics, Inc., and Zimmer Biomet Group.

Market Segmentation & Coverage

This research report categorizes the Transplant Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

Offering
Instruments
Reagents & Consumables
Software & Services
Technology
Molecular Assays
Non-Molecular Assays
Transplant
Soft Tissue Transplant
Solid Organ Transplant
Stem Cell Transplant
Application
Diagnostic Applications
Research Applications
End User
Hospitals & Transplant Centers
Independent Reference Laboratories
Research Laboratories & Academic Institutes
Region
Americas
Argentina

Brazil

Canada

Mexico

United States
California

Florida

Illinois

New York

Ohio

Pennsylvania

Texas
Asia-Pacific
Australia

China

India

Indonesia

Japan

Malaysia

Philippines

Singapore

South Korea

Taiwan

Thailand

Vietnam
Europe, Middle East & Africa
Denmark

Egypt

Finland

France

Germany

Israel

Italy

Netherlands

Nigeria

Norway

Poland

Qatar

Russia

Saudi Arabia

South Africa

Spain

Sweden

Switzerland

Turkey

United Arab Emirates

United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Transplant Diagnostics Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Transplant Diagnostics Market?
3. What are the technology trends and regulatory frameworks in the Transplant Diagnostics Market?
4. What is the market share of the leading vendors in the Transplant Diagnostics Market?
5. Which modes and strategic moves are suitable for entering the Transplant Diagnostics Market?

Note: PDF & Excel + Online Access - 1 Year

Table of Contents

191 Pages
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Transplant Diagnostics Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing awareness for organ donation and rise in organ transplant
5.1.1.2. Increased focus on research & development of transplant diagnostics
5.1.1.3. Growing medical tourism in developing countries
5.1.2. Restraints
5.1.2.1. High cost associated with organ transplant procedures
5.1.3. Opportunities
5.1.3.1. Increasing technological advancements in transplant diagnostics
5.1.3.2. Growing regulatory guidelines for organ transplant
5.1.4. Challenges
5.1.4.1. Lack of insurance and reimbursement policies and complications of organ transplant
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Transplant Diagnostics Market, by Offering
6.1. Introduction
6.2. Instruments
6.3. Reagents & Consumables
6.4. Software & Services
7. Transplant Diagnostics Market, by Technology
7.1. Introduction
7.2. Molecular Assays
7.3. Non-Molecular Assays
8. Transplant Diagnostics Market, by Transplant
8.1. Introduction
8.2. Soft Tissue Transplant
8.3. Solid Organ Transplant
8.4. Stem Cell Transplant
9. Transplant Diagnostics Market, by Application
9.1. Introduction
9.2. Diagnostic Applications
9.3. Research Applications
10. Transplant Diagnostics Market, by End User
10.1. Introduction
10.2. Hospitals & Transplant Centers
10.3. Independent Reference Laboratories
10.4. Research Laboratories & Academic Institutes
11. Americas Transplant Diagnostics Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Transplant Diagnostics Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Transplant Diagnostics Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.2. Market Share Analysis, By Key Player
14.3. Competitive Scenario Analysis, By Key Player
14.3.1. Merger & Acquisition
14.3.1.1. Werfen to acquire transfusion and transplant diagnostics innovator for around USD 2 billion
14.3.1.2. Thermo Fisher will buy the binding site for $2.6B to gain specialty diagnostics portfolio
14.3.1.3. GenDx to develop NGS-Turbo following agreement with Oxford Nanopore Technologies
14.3.1.4. Eurobio Scientific buys Dutch transplant diagnostics firm GenDx for €135 million
14.3.2. Agreement, Collaboration, & Partnership
14.3.2.1. Immucor and Pirche announce multi-year partnership
14.3.3. New Product Launch & Enhancement
14.3.3.1. Quest Diagnostics unveils advanced transplant diagnostic services featuring anywhere-access in the United States
14.3.3.2. Eurofins Scientific SE: Transplant Genomics announces the launch of Trugraf Liver, the first and only non-invasive gene expression diagnostic test to optimize immunosuppression in liver transplant recipients
14.3.3.3. Immucor announces innovations in transplant diagnostics
14.3.4. Award, Recognition, & Expansion
14.3.4.1. Plexision launches personalized transplant diagnostic testing in India
14.3.4.2. Eurofins Viracor opens expansive laboratory in Lenexa, KS
14.3.4.3. Hologic announces FDA approval of Aptima CMV Quant Assay For Human Cytomegalovirus
15. Competitive Portfolio
15.1. Key Company Profiles
15.1.1. Abbott Laboratories
15.1.2. Adaptive Biotechnologies Corporation
15.1.3. altona Diagnostics GmbH
15.1.4. Arquer Diagnostics Ltd.
15.1.5. BAG Group
15.1.6. Becton, Dickinson and Company
15.1.7. Bio-Rad Laboratories, Inc.
15.1.8. Biogenuix Medsystems Pvt. Ltd
15.1.9. BioMérieux SA
15.1.10. Bruker Corporation
15.1.11. CareDx, Inc.
15.1.12. CLONIT srl
15.1.13. Diagnóstica Longwood SL
15.1.14. DiaSorin S.p.A.
15.1.15. Eurofins Scientific SE
15.1.16. F. Hoffmann-La Roche Ltd.
15.1.17. Genome Diagnostics B.V.
15.1.18. Hologic, Inc.
15.1.19. Illumina, Inc
15.1.20. Immucor, Inc.
15.1.21. Laboratory Corporation of America Holdings
15.1.22. Luminex Corporation
15.1.23. Merck KGaA
15.1.24. NanoString Technologies, Inc.
15.1.25. Novartis AG
15.1.26. PathoNostics B.V
15.1.27. QIAGEN, N.V.
15.1.28. Quest Diagnostics Incorporated
15.1.29. Randox Laboratories Ltd.
15.1.30. Takara Bio Inc.
15.1.31. Thermo Fisher Scientific Inc.
15.1.32. TransMedics, Inc.
15.1.33. Zimmer Biomet Group
15.2. Key Product Portfolio
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing
FIGURE 1. TRANSPLANT DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 2. TRANSPLANT DIAGNOSTICS MARKET SIZE, 2023 VS 2030
FIGURE 3. TRANSPLANT DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. TRANSPLANT DIAGNOSTICS MARKET DYNAMICS
FIGURE 7. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2023 VS 2030 (%)
FIGURE 8. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 10. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2023 VS 2030 (%)
FIGURE 12. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 14. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 16. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 20. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. TRANSPLANT DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 26. TRANSPLANT DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us